0000925421-17-000346.txt : 20170925 0000925421-17-000346.hdr.sgml : 20170925 20170925164740 ACCESSION NUMBER: 0000925421-17-000346 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170919 FILED AS OF DATE: 20170925 DATE AS OF CHANGE: 20170925 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krishnan Suma CENTRAL INDEX KEY: 0001298711 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38210 FILM NUMBER: 171100216 MAIL ADDRESS: STREET 1: 1861 PRATT DRIVE STREET 2: SUITE 1090 CITY: BLACKSBURG STATE: VA ZIP: 24060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 810930882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 3/A 1 edgar.xml PRIMARY DOCUMENT X0206 3/A 2017-09-19 2017-09-19 0 0001711279 Krystal Biotech, Inc. KRYS 0001298711 Krishnan Suma C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203 1 1 1 0 Chief Operating Officer Series A Convertible Preferred Stock Common Stock 112162 I By trust The Series A convertible preferred stock will automatically convert on a one-to-one basis into 112,162 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering. These shares were incorrectly included in the Non-Derivative Securities table in the reporting person's original Form 3, filed September 19, 2017. The Krishnan Family Trust beneficially owns 112,162 shares of Series A convertible preferred stock. The reporting person and his spouse are each joint beneficial owners of the trust with joint voting and investment control. /s/ Katherine A. Shaia,as attorney-in-fact for Suma M. Krishnan 2017-09-25